MedinCell has launched a COVID-19 research initiative based on its experience to formulate long-acting injectable Ivermectin
6 April 2020
Our news
Bringing you the latest!
Investors
MedinCell receives $ 6.4 million grant from Unitaid to fight Malaria
25 March 2020
MedinCell provides a portfolio update for J.P. Morgan Healthcare Conference 2020
13 January 2020
Publication of the activity report and financial information for the first half-year (April – Sept. 2019)
3 December 2019
MedinCell announces that mdc-CWM progresses as planned
27 September 2019
MedinCell receives a new grant to develop a best-in-class long-acting injectable product for HIV PrEP
5 September 2019
MedinCell partners to address the untapped financial potential in Animal Health
28 August 2019
LAI antipsychotic using MedinCell’s technology receives FDA IND clearance to initiate clinical activities
26 August 2019